XENT Trims Revenue Outlook, CTXR On Watch, Busy Year Ahead For NLNK

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

from RTT - Biotech https://ift.tt/2Aul50U
via IFTTT